Dana-Farber Cancer Institute is a nonprofit cancer research and treatment center based in Boston, Massachusetts. Founded in 1947 by Sidney Farber, it is a teaching affiliate of Harvard Medical School and an NCI-designated Comprehensive Cancer Center. Adult oncology care is provided in collaboration with Brigham and Women’s Hospital, and pediatric oncology care with Boston Children’s Hospital.
Dana-Farber conducts basic, translational, and clinical research across oncology and hematology, including precision medicine, immuno-oncology, and biomarker-guided therapies. The institute operates extensive clinical trials programs and collaborates with academic, government, and industry partners to advance drug discovery and development. Its activities span laboratory science, computational biology, and population sciences to inform prevention, diagnosis, and treatment of cancer.
Official website: dana-farber.org
To provide comprehensive coverage, we aggregate data and news under the name Dana-Farber, encompassing the following company names, divisions, and related entities:
Lank Center for Genitourinary Oncology and DFCI.
This list encompasses current and former names, alternate names, and key divisions associated with Dana-Farber, ensuring you can easily find all relevant information under a single, unified profile.
